Non Alcoholic Steatohepatitis Nash Market Size And Share

  • Report Code : TIPRE00009653
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, and Growth 2022-2028

Buy Now

Non-Alcoholic Steatohepatitis Market Report Non-Alcoholic Steatohepatitis Market Scope and Analysis Non-Alcoholic Steatohepatitis Market Size and Share

Non-Alcoholic Steatohepatitis Market: Strategic Insights

Non-Alcoholic Steatohepatitis Market

  • CAGR (2023 - 2031)
    47.10%
  • Market Size 2023
    US$ 3.53 Billion
  • Market Size 2031
    US$ 77.42 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing Initiatives for the Awareness of NASH Favors the Market Growth
FUTURE TRENDS
  • Growing Clinical Trials Involving Combination Studies of Drugs
OPPORTUNITIES
  • High Competition among Market Players to Manufacture the First Marketed NASH Drug Creates Global Sales Opportunity

Key Players

  • Genfit SA
  • One Way Liver S L
  • BioPredictive S A S
  • Cadila Pharmaceuticals Ltd
  • Prometheus Laboratories
  • Siemens Healthineers AG
  • Intercept Pharmaceuticals Inc
  • Novartis AG
  • Galmed Pharmaceuticals
  • Laboratory Corporation of America Holdings

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Vitamin E and Pioglitazone
  • Ocaliva
  • Elafibranor
  • Selonsertib & Cenicriviroc
Application
  • Treatment and Diagnosis
Sales Channel
  • Hospital Pharmacy
  • Online Provider
  • Retail Pharmacy